|
|
|
|
|
|
|
Request your FREE Special Report today and you'll |
Shares of MediciNova, Inc. (Nasdaq: MNOV) are sagging this morning in pre-market trading after the a biopharmaceutical company said that its Phase IIa trial for the treatment of insomnia failed.
Shares of MediciNova (MNOV) slipped 9.4%, or $0.70, to $6.75 in pre-market trading. Shares of MediciNova have been trading in the range of $6.35 to $16.12 for the 52 weeks.
Join Daily Profit today and get our unique perspective and investment ideas in your inbox every day.
Please tell us where we can send your free subscription. Plus, as a free gift, I'll rush you a copy of my Top 10 Forever Stocks - a special bonus report.
Wyatt Investment Research
c/o Business Financial Publishing
65 Railroad Street
PO Box 790
Richmond, VT 05477
